Yujung Skibo
Nurse Practitioner · Belfast, MENPI 1972870632
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,154 of the $1,746 with a category attached, or 66.1%. It is spread thinly across 25 manufacturers, the largest accounting for just 19.3%. Reporting peaked in 2022 at $1,702 and has fallen 98.4% since, to $28 in 2025. Among nurse practitioner clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $29.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$338
- Pfizer$194
- Lilly USA, LLC$180
- Johnson & Johnson$177
- Incyte Corporation$150
- Novartis$86
- plus $621 from 19 others
What the payments were for
- Food & beverage$1,15466%
- Education$59234%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 7 | $338 |
| Pfizer | 6 | $194 |
| Lilly USA, LLC | 4 | $180 |
| Johnson & Johnson | 4 | $177 |
| Incyte Corporation | 4 | $150 |
| Novartis | 5 | $86 |
| Amgen | 4 | $82 |
| Sanofi | 3 | $74 |
| Merck | 3 | $61 |
| Ipsen Biopharmaceuticals, Inc | 3 | $49 |
| Genentech USA, Inc. | 2 | $48 |
| Astellas Pharma US Inc | 2 | $38 |
| AbbVie | 1 | $28 |
| Gilead | 1 | $27 |
| Eisai Inc. | 1 | $24 |
| Dendreon Pharmaceuticals LLC | 1 | $23 |
| Puma Biotechnology, Inc. | 1 | $22 |
| Boehringer Ingelheim | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $21 |
| Beigene USA, Inc. | 1 | $21 |
| EUSA Pharma (US) LLC | 1 | $19 |
| Bayer | 1 | $18 |
| Blueprint Medicines Corporation | 1 | $16 |
| Kyowa Kirin, Inc. | 1 | $15 |
| G1 Therapeutics, Inc. | 1 | $12 |
How this compares
$1,746 in reported general payments places this provider in the 95th percentile of 740 nurse practitioner providers in Maine.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Anastrozole | 17 | $430 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Belfast
- Wenda CollienBelfast$3K
- Amanda MagnoliWestbrook$113K
- Gisele CastonguayLewiston$26K
- Rachel Koransky-MatsonBangor$16K
- Denise ViekmanPortland$15K
- Kerri NeelYork$5K
- Mallory EvansYork$5K
- Karrie SweetPortland$5K
- Noelle CooperSouth Portland$4K
- Kimberlee SmithKittery$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.